The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lung Cancer Biomarkers Market Research Report 2024
Synopsis
Due to the COVID-19 pandemic, the global Lung Cancer Biomarkers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Lung Cancer Biomarkers market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Lung Cancer Biomarkers landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Protein Biomarker accounting for % of the Lung Cancer Biomarkers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Diagnostics segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Lung Cancer Biomarkers include Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomerieux SA, Merck and Abbott Laboratories, etc. In terms of revenue, the global 3 largest players have a % market share of Lung Cancer Biomarkers in 2021.
This report focuses on Lung Cancer Biomarkers volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Lung Cancer Biomarkers market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Lung Cancer Biomarkers Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Protein Biomarker
Genetic Biomarker
Segment by Application
Diagnostics
Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomerieux SA
Merck
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Due to the COVID-19 pandemic, the global Lung Cancer Biomarkers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Lung Cancer Biomarkers market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Lung Cancer Biomarkers landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Protein Biomarker accounting for % of the Lung Cancer Biomarkers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Diagnostics segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Lung Cancer Biomarkers include Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomerieux SA, Merck and Abbott Laboratories, etc. In terms of revenue, the global 3 largest players have a % market share of Lung Cancer Biomarkers in 2021.
This report focuses on Lung Cancer Biomarkers volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Lung Cancer Biomarkers market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Lung Cancer Biomarkers Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Protein Biomarker
Genetic Biomarker
Segment by Application
Diagnostics
Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomerieux SA
Merck
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Index1 Lung Cancer Biomarkers Market Overview
1.1 Product Overview and Scope of Lung Cancer Biomarkers
1.2 Lung Cancer Biomarkers Segment by Type
1.2.1 Global Lung Cancer Biomarkers Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Protein Biomarker
1.2.3 Genetic Biomarker
1.3 Lung Cancer Biomarkers Segment by Application
1.3.1 Global Lung Cancer Biomarkers Sales Comparison by Application: (2022-2028)
1.3.2 Diagnostics
1.3.3 Research
1.3.4 Others
1.4 Global Lung Cancer Biomarkers Market Size Estimates and Forecasts
1.4.1 Global Lung Cancer Biomarkers Revenue 2017-2028
1.4.2 Global Lung Cancer Biomarkers Sales 2017-2028
1.4.3 Lung Cancer Biomarkers Market Size by Region: 2017 Versus 2021 Versus 2028
2 Lung Cancer Biomarkers Market Competition by Manufacturers
2.1 Global Lung Cancer Biomarkers Sales Market Share by Manufacturers (2017-2022)
2.2 Global Lung Cancer Biomarkers Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Lung Cancer Biomarkers Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Lung Cancer Biomarkers Manufacturing Sites, Area Served, Product Type
2.5 Lung Cancer Biomarkers Market Competitive Situation and Trends
2.5.1 Lung Cancer Biomarkers Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Lung Cancer Biomarkers Players Market Share by Revenue
2.5.3 Global Lung Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lung Cancer Biomarkers Retrospective Market Scenario by Region
3.1 Global Lung Cancer Biomarkers Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Lung Cancer Biomarkers Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Lung Cancer Biomarkers Market Facts & Figures by Country
3.3.1 North America Lung Cancer Biomarkers Sales by Country
3.3.2 North America Lung Cancer Biomarkers Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Lung Cancer Biomarkers Market Facts & Figures by Country
3.4.1 Europe Lung Cancer Biomarkers Sales by Country
3.4.2 Europe Lung Cancer Biomarkers Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lung Cancer Biomarkers Market Facts & Figures by Region
3.5.1 Asia Pacific Lung Cancer Biomarkers Sales by Region
3.5.2 Asia Pacific Lung Cancer Biomarkers Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Lung Cancer Biomarkers Market Facts & Figures by Country
3.6.1 Latin America Lung Cancer Biomarkers Sales by Country
3.6.2 Latin America Lung Cancer Biomarkers Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Lung Cancer Biomarkers Market Facts & Figures by Country
3.7.1 Middle East and Africa Lung Cancer Biomarkers Sales by Country
3.7.2 Middle East and Africa Lung Cancer Biomarkers Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Lung Cancer Biomarkers Historic Market Analysis by Type
4.1 Global Lung Cancer Biomarkers Sales Market Share by Type (2017-2022)
4.2 Global Lung Cancer Biomarkers Revenue Market Share by Type (2017-2022)
4.3 Global Lung Cancer Biomarkers Price by Type (2017-2022)
5 Global Lung Cancer Biomarkers Historic Market Analysis by Application
5.1 Global Lung Cancer Biomarkers Sales Market Share by Application (2017-2022)
5.2 Global Lung Cancer Biomarkers Revenue Market Share by Application (2017-2022)
5.3 Global Lung Cancer Biomarkers Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bio-Rad Laboratories
6.1.1 Bio-Rad Laboratories Corporation Information
6.1.2 Bio-Rad Laboratories Description and Business Overview
6.1.3 Bio-Rad Laboratories Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bio-Rad Laboratories Lung Cancer Biomarkers Product Portfolio
6.1.5 Bio-Rad Laboratories Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Corporation Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Roche Diagnostics Lung Cancer Biomarkers Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 Qiagen
6.3.1 Qiagen Corporation Information
6.3.2 Qiagen Description and Business Overview
6.3.3 Qiagen Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Qiagen Lung Cancer Biomarkers Product Portfolio
6.3.5 Qiagen Recent Developments/Updates
6.4 Illumina
6.4.1 Illumina Corporation Information
6.4.2 Illumina Description and Business Overview
6.4.3 Illumina Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Illumina Lung Cancer Biomarkers Product Portfolio
6.4.5 Illumina Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Corporation Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GE Healthcare Lung Cancer Biomarkers Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Agilent Technologies
6.6.1 Agilent Technologies Corporation Information
6.6.2 Agilent Technologies Description and Business Overview
6.6.3 Agilent Technologies Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Agilent Technologies Lung Cancer Biomarkers Product Portfolio
6.6.5 Agilent Technologies Recent Developments/Updates
6.7 Biomerieux SA
6.6.1 Biomerieux SA Corporation Information
6.6.2 Biomerieux SA Description and Business Overview
6.6.3 Biomerieux SA Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Biomerieux SA Lung Cancer Biomarkers Product Portfolio
6.7.5 Biomerieux SA Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Merck Lung Cancer Biomarkers Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Abbott Laboratories Lung Cancer Biomarkers Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Becton, Dickinson and Company
6.10.1 Becton, Dickinson and Company Corporation Information
6.10.2 Becton, Dickinson and Company Description and Business Overview
6.10.3 Becton, Dickinson and Company Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Becton, Dickinson and Company Lung Cancer Biomarkers Product Portfolio
6.10.5 Becton, Dickinson and Company Recent Developments/Updates
6.11 Danaher Corporation
6.11.1 Danaher Corporation Corporation Information
6.11.2 Danaher Corporation Lung Cancer Biomarkers Description and Business Overview
6.11.3 Danaher Corporation Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Danaher Corporation Lung Cancer Biomarkers Product Portfolio
6.11.5 Danaher Corporation Recent Developments/Updates
6.12 Myriad Genetics
6.12.1 Myriad Genetics Corporation Information
6.12.2 Myriad Genetics Lung Cancer Biomarkers Description and Business Overview
6.12.3 Myriad Genetics Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Myriad Genetics Lung Cancer Biomarkers Product Portfolio
6.12.5 Myriad Genetics Recent Developments/Updates
6.13 Sysmex Corporation
6.13.1 Sysmex Corporation Corporation Information
6.13.2 Sysmex Corporation Lung Cancer Biomarkers Description and Business Overview
6.13.3 Sysmex Corporation Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Sysmex Corporation Lung Cancer Biomarkers Product Portfolio
6.13.5 Sysmex Corporation Recent Developments/Updates
6.14 Hologic
6.14.1 Hologic Corporation Information
6.14.2 Hologic Lung Cancer Biomarkers Description and Business Overview
6.14.3 Hologic Lung Cancer Biomarkers Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Hologic Lung Cancer Biomarkers Product Portfolio
6.14.5 Hologic Recent Developments/Updates
7 Lung Cancer Biomarkers Manufacturing Cost Analysis
7.1 Lung Cancer Biomarkers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lung Cancer Biomarkers
7.4 Lung Cancer Biomarkers Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lung Cancer Biomarkers Distributors List
8.3 Lung Cancer Biomarkers Customers
9 Lung Cancer Biomarkers Market Dynamics
9.1 Lung Cancer Biomarkers Industry Trends
9.2 Lung Cancer Biomarkers Market Drivers
9.3 Lung Cancer Biomarkers Market Challenges
9.4 Lung Cancer Biomarkers Market Restraints
10 Global Market Forecast
10.1 Lung Cancer Biomarkers Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Lung Cancer Biomarkers by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Lung Cancer Biomarkers by Type (2023-2028)
10.2 Lung Cancer Biomarkers Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Lung Cancer Biomarkers by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Lung Cancer Biomarkers by Application (2023-2028)
10.3 Lung Cancer Biomarkers Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lung Cancer Biomarkers by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Lung Cancer Biomarkers by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Lung Cancer Biomarkers Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Lung Cancer Biomarkers Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Lung Cancer Biomarkers Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Lung Cancer Biomarkers Market Competitive Situation by Manufacturers in 2021
Table 5. Global Lung Cancer Biomarkers Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Lung Cancer Biomarkers Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Lung Cancer Biomarkers Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Lung Cancer Biomarkers Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Lung Cancer Biomarkers Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Lung Cancer Biomarkers Manufacturing Sites and Area Served
Table 11. Manufacturers Lung Cancer Biomarkers Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Lung Cancer Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Biomarkers as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Lung Cancer Biomarkers Sales by Region (2017-2022) & (Units)
Table 16. Global Lung Cancer Biomarkers Sales Market Share by Region (2017-2022)
Table 17. Global Lung Cancer Biomarkers Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Lung Cancer Biomarkers Revenue Market Share by Region (2017-2022)
Table 19. North America Lung Cancer Biomarkers Sales by Country (2017-2022) & (Units)
Table 20. North America Lung Cancer Biomarkers Sales Market Share by Country (2017-2022)
Table 21. North America Lung Cancer Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Lung Cancer Biomarkers Revenue Market Share by Country (2017-2022)
Table 23. Europe Lung Cancer Biomarkers Sales by Country (2017-2022) & (Units)
Table 24. Europe Lung Cancer Biomarkers Sales Market Share by Country (2017-2022)
Table 25. Europe Lung Cancer Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Lung Cancer Biomarkers Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Lung Cancer Biomarkers Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Lung Cancer Biomarkers Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Lung Cancer Biomarkers Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Lung Cancer Biomarkers Revenue Market Share by Region (2017-2022)
Table 31. Latin America Lung Cancer Biomarkers Sales by Country (2017-2022) & (Units)
Table 32. Latin America Lung Cancer Biomarkers Sales Market Share by Country (2017-2022)
Table 33. Latin America Lung Cancer Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Lung Cancer Biomarkers Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Lung Cancer Biomarkers Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Lung Cancer Biomarkers Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Lung Cancer Biomarkers Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Lung Cancer Biomarkers Revenue Market Share by Country (2017-2022)
Table 39. Global Lung Cancer Biomarkers Sales by Type (2017-2022) & (Units)
Table 40. Global Lung Cancer Biomarkers Sales Market Share by Type (2017-2022)
Table 41. Global Lung Cancer Biomarkers Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Lung Cancer Biomarkers Revenue Share by Type (2017-2022)
Table 43. Global Lung Cancer Biomarkers Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Lung Cancer Biomarkers Sales (Units) by Application (2017-2022)
Table 45. Global Lung Cancer Biomarkers Sales Market Share by Application (2017-2022)
Table 46. Global Lung Cancer Biomarkers Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Lung Cancer Biomarkers Revenue Share by Application (2017-2022)
Table 48. Global Lung Cancer Biomarkers Price by Application (2017-2022) & (US$/Unit)
Table 49. Bio-Rad Laboratories Corporation Information
Table 50. Bio-Rad Laboratories Description and Business Overview
Table 51. Bio-Rad Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Bio-Rad Laboratories Lung Cancer Biomarkers Product
Table 53. Bio-Rad Laboratories Recent Developments/Updates
Table 54. Roche Diagnostics Corporation Information
Table 55. Roche Diagnostics Description and Business Overview
Table 56. Roche Diagnostics Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Roche Diagnostics Lung Cancer Biomarkers Product
Table 58. Roche Diagnostics Recent Developments/Updates
Table 59. Qiagen Corporation Information
Table 60. Qiagen Description and Business Overview
Table 61. Qiagen Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Qiagen Lung Cancer Biomarkers Product
Table 63. Qiagen Recent Developments/Updates
Table 64. Illumina Corporation Information
Table 65. Illumina Description and Business Overview
Table 66. Illumina Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Illumina Lung Cancer Biomarkers Product
Table 68. Illumina Recent Developments/Updates
Table 69. GE Healthcare Corporation Information
Table 70. GE Healthcare Description and Business Overview
Table 71. GE Healthcare Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. GE Healthcare Lung Cancer Biomarkers Product
Table 73. GE Healthcare Recent Developments/Updates
Table 74. Agilent Technologies Corporation Information
Table 75. Agilent Technologies Description and Business Overview
Table 76. Agilent Technologies Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Agilent Technologies Lung Cancer Biomarkers Product
Table 78. Agilent Technologies Recent Developments/Updates
Table 79. Biomerieux SA Corporation Information
Table 80. Biomerieux SA Description and Business Overview
Table 81. Biomerieux SA Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Biomerieux SA Lung Cancer Biomarkers Product
Table 83. Biomerieux SA Recent Developments/Updates
Table 84. Merck Corporation Information
Table 85. Merck Description and Business Overview
Table 86. Merck Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Merck Lung Cancer Biomarkers Product
Table 88. Merck Recent Developments/Updates
Table 89. Abbott Laboratories Corporation Information
Table 90. Abbott Laboratories Description and Business Overview
Table 91. Abbott Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Abbott Laboratories Lung Cancer Biomarkers Product
Table 93. Abbott Laboratories Recent Developments/Updates
Table 94. Becton, Dickinson and Company Corporation Information
Table 95. Becton, Dickinson and Company Description and Business Overview
Table 96. Becton, Dickinson and Company Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Becton, Dickinson and Company Lung Cancer Biomarkers Product
Table 98. Becton, Dickinson and Company Recent Developments/Updates
Table 99. Danaher Corporation Corporation Information
Table 100. Danaher Corporation Description and Business Overview
Table 101. Danaher Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Danaher Corporation Lung Cancer Biomarkers Product
Table 103. Danaher Corporation Recent Developments/Updates
Table 104. Myriad Genetics Corporation Information
Table 105. Myriad Genetics Description and Business Overview
Table 106. Myriad Genetics Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Myriad Genetics Lung Cancer Biomarkers Product
Table 108. Myriad Genetics Recent Developments/Updates
Table 109. Sysmex Corporation Corporation Information
Table 110. Sysmex Corporation Description and Business Overview
Table 111. Sysmex Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Sysmex Corporation Lung Cancer Biomarkers Product
Table 113. Sysmex Corporation Recent Developments/Updates
Table 114. Hologic Corporation Information
Table 115. Hologic Description and Business Overview
Table 116. Hologic Lung Cancer Biomarkers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Hologic Lung Cancer Biomarkers Product
Table 118. Hologic Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Lung Cancer Biomarkers Distributors List
Table 122. Lung Cancer Biomarkers Customers List
Table 123. Lung Cancer Biomarkers Market Trends
Table 124. Lung Cancer Biomarkers Market Drivers
Table 125. Lung Cancer Biomarkers Market Challenges
Table 126. Lung Cancer Biomarkers Market Restraints
Table 127. Global Lung Cancer Biomarkers Sales Forecast by Type (2023-2028) & (Units)
Table 128. Global Lung Cancer Biomarkers Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Lung Cancer Biomarkers Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Lung Cancer Biomarkers Sales Forecast by Application (2023-2028) & (Units)
Table 132. Global Lung Cancer Biomarkers Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Lung Cancer Biomarkers Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Lung Cancer Biomarkers Sales Forecast by Region (2023-2028) & (Units)
Table 136. Global Lung Cancer Biomarkers Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Lung Cancer Biomarkers Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Lung Cancer Biomarkers Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lung Cancer Biomarkers
Figure 2. Global Lung Cancer Biomarkers Market Share by Type in 2021 & 2028
Figure 3. Protein Biomarker Product Picture
Figure 4. Genetic Biomarker Product Picture
Figure 5. Global Lung Cancer Biomarkers Market Share by Application in 2021 & 2028
Figure 6. Diagnostics
Figure 7. Research
Figure 8. Others
Figure 9. Global Lung Cancer Biomarkers Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Lung Cancer Biomarkers Market Size (2017-2028) & (US$ Million)
Figure 11. Global Lung Cancer Biomarkers Sales (2017-2028) & (Units)
Figure 12. Lung Cancer Biomarkers Sales Share by Manufacturers in 2021
Figure 13. Global Lung Cancer Biomarkers Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Lung Cancer Biomarkers Players: Market Share by Revenue in 2021
Figure 15. Lung Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Lung Cancer Biomarkers Sales Market Share by Region (2017-2022)
Figure 17. Global Lung Cancer Biomarkers Sales Market Share by Region in 2021
Figure 18. Global Lung Cancer Biomarkers Revenue Market Share by Region (2017-2022)
Figure 19. Global Lung Cancer Biomarkers Revenue Market Share by Region in 2021
Figure 20. United States Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Lung Cancer Biomarkers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Lung Cancer Biomarkers by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Lung Cancer Biomarkers
Figure 44. Manufacturing Process Analysis of Lung Cancer Biomarkers
Figure 45. Lung Cancer Biomarkers Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
